微信关注
Total item
Cart Subtotal
￥ 0.00 Purinergic (P2Y) Receptors
13 个项目
每页
-
Cangrelor Tetrasodium
Catalog No. A17919 P2Y12 receptors inhibitorCangrelor Tetrasodium is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. 了解更多 -
Clopidogrel thiolactone
Catalog No. A20862 P2Y12 receptor inhibitorClopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent. 了解更多 -
Prasugrel (Effient)
Catalog No. A10748 platelet inhibitorPrasugrel (Effient)是一种新型的血小板抑制剂，用于减少急性冠脉综合征（PCI）患者的血栓性心血管事件（包括支架血栓形成）。 了解更多 -
(+)-Clopidogrel hydrogen sulfate (Plavix)
Catalog No. A10233 (+)-Clopidogrel hydrogen sulfate (Plavix)是一种口服的，噻吩吡啶类抗血小板药物。 了解更多 -
Ticagrelor (AZD6140)
Catalog No. A11238 -
AZD1283
Catalog No. A15443 -
Prasugrel Hydrochloride
Catalog No. A16144 -
Clopidogrel
Catalog No. A21206 platelet inhibitorClopidogrel is a well-known and orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. 了解更多
13 个项目
每页
FILTER BY:
购物选项
- 作用机制
-
- Inhibitor (抑制剂) (5)
- Antagonist (拮抗剂) (6)
ADOOQ 产品质量保证
We promise all products to perform as described.